Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
2197–2232
Headlines
2431
Sources here
17
Companies here
18
Current section United States Medical Care Facilities news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

(AMN) Movement as an Input in Quant Signal Sets

This article provides an in-depth AI-driven analysis for Amn Healthcare Services Inc (AMN), indicating strong sentiment across all time horizons and compelling upside potential due to a lack of current resistance levels. It outlines specific institutional trading strategies, including long, breakout, and short positions, …

AMN main company
Sharemaestro market context Trend signal active 52 weeks +66.3% AMN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Outpatient & Specialty Care Stocks Q1 Highlights: U.S. Physical Therapy (NYSE:USPH)

This article analyzes the Q1 performance of U.S. Physical Therapy (NYSE:USPH) and its peers in the outpatient and specialty care industry. While the sector generally showed strong Q1 results, U.S. Physical Therapy delivered the weakest performance against analyst estimates, with its stock down 1.5% …

DVA mentioned USPH mentioned
Sharemaestro market context Trend signal active 52 weeks +28.3% DVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wells Fargo Maintains Agilon Health(AGL.US) With Buy Rating, Maintains Target Price $141

Wells Fargo has reiterated its "Buy" rating for Agilon Health (AGL.US), maintaining a price target of $141. This indicates the firm's continued positive outlook on the company's stock performance.

AGL main company
Sharemaestro market context Trend signal active 52 weeks +191.4% · Next-week setup positive 57.8% AGL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insider Sell: Mark Hancock Sells Shares of PACS Group Inc

Mark Hancock, a Director and 10% Owner of PACS Group Inc (PACS), sold 13,628 shares of the company on July 15, 2026, reducing his holding to 53,906,884 shares. This transaction is part of a larger trend where Hancock has sold 636,320 shares over the …

PACS main company
Sharemaestro market context Trend signal active 52 weeks +268.8% PACS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Oncology Institute, Inc. (TOI) CMO sells 23,452 shares after option exercises

Oncology Institute, Inc. Chief Medical Officer Yale Podnos sold a total of 23,452 common shares on July 14, 2026, after exercising stock options. The shares were sold at prices ranging from $6.35 to $6.429 under a pre-arranged Rule 10(b)5-1 trading plan. Following these transactions, …

TOI main company
Sharemaestro market context Trend signal active 52 weeks +13.6% TOI stored weekly price path from 8 Aug 2025 to 31 Jul 2026

Oncology institute CMO Yale Podnos sells $150k in shares

Yale Podnos, Chief Medical Officer of Oncology Institute, Inc. (NASDAQ:TOI), recently sold $150,340 worth of common stock after exercising options. The sales were part of a Rule 10b5-1 trading plan. Despite the stock's recent decline, it remains up significantly over the past year, and …

TOI main company
Sharemaestro market context Trend signal active 52 weeks +13.6% TOI stored weekly price path from 8 Aug 2025 to 31 Jul 2026

MD4766160 Bond Risk Profile

This page provides a risk profile for the MD4766160 bond, issued by Pediatrix Medical Group, Inc. with a 6.25% coupon maturing on January 15, 2027. It offers an overview of key metrics for credit risk assessment, including security level, inflation protection, and issuer rating, …

MD mentioned
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PACS Group president & COO Joshua Jergensen sells $1.8m in stock

Joshua Jergensen, President & COO of PACS Group, Inc. (PACS), sold 40,000 shares of the company’s common stock for over $1.8 million on July 15, 2026, under a Rule 10b5-1 trading plan. The sale occurred as PACS's stock was trading near its 52-week high …

PACS main company
Sharemaestro market context Trend signal active 52 weeks +268.8% PACS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PACS Group (PACS) director and 10% owner sells 13,628 shares under plan

Mark Hancock, a director and 10% owner of PACS Group (PACS), sold a total of 13,628 shares of common stock on July 14 and 15, 2026. The sales were conducted under a Rule 10b5-1 trading plan and occurred at weighted average prices of $45.0350 …

PACS main company
Sharemaestro market context Trend signal active 52 weeks +268.8% PACS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PACS Group, Inc. (NYSE: PACS) COO sells 40,000 shares in 10b5-1 trades

Joshua Jergensen, President and COO of PACS Group, Inc. (NYSE: PACS), sold a total of 40,000 shares of common stock on July 15, 2026. These sales were conducted through three open-market transactions under a Rule 10b5-1 trading plan adopted on March 12, 2026, with …

PACS main company
Sharemaestro market context Trend signal active 52 weeks +268.8% PACS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rehabilitation hospital planned in Post Falls

Encompass Health Corp. is planning to build a new 50-bed rehabilitation hospital in Post Falls, Idaho, expected to open in 2028. This 55,000-square-foot facility will address the limited rehabilitation bed availability in the region, serving Post Falls, Coeur d’Alene, and surrounding areas. The hospital, …

EHC main company
Sharemaestro market context Trend signal active 52 weeks +1.1% · Next-week setup positive 55.9% EHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Oncology Institute (TOI) One of the Best Future Stocks to Buy Under $10?

The Oncology Institute (TOI) recently completed a strategic refinancing deal with OrbiMed, securing a $75 million term loan and repaying its previous $86 million debt. This move is expected to strengthen its balance sheet, extend debt maturities, and improve liquidity without diluting existing shareholders. …

TOI main company
Sharemaestro market context Trend signal active 52 weeks +13.6% TOI stored weekly price path from 8 Aug 2025 to 31 Jul 2026

Form 4 Encompass Health Corp For: 16 July By Investing.com

This article from Investing.com is a placeholder announcing the Form 4 filing for Encompass Health Corp (EHC) on July 16, 2026. It indicates that further details would typically be found within the filing itself, which is a regulatory document disclosing insider transactions. The article …

EHC main company
Sharemaestro market context Trend signal active 52 weeks +1.1% · Next-week setup positive 55.9% EHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DaVita Inc. stock underperforms Thursday when compared to competitors despite daily gains

DaVita Inc. (DVA) saw its stock advance by 1.04% on Thursday, closing at $234.01. Despite this gain, the stock underperformed against a grim overall market, with the S&P 500 and Dow Jones Industrial Average both experiencing declines. This rise for DaVita Inc. ended a …

DVA main company
Sharemaestro market context Trend signal active 52 weeks +28.3% DVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Encompass Health (NYSE: EHC) director credited 19 RSUs tied to $0.19 dividend

Encompass Health Corp. director Kevin J. O'Connor received an automatic grant of 19 Restricted Stock Units (RSUs) on July 15, 2026, linked to a $0.19 per-share dividend. These RSUs were credited under existing agreements and valued at $0.00 per share, with the stock closing …

EHC main company
Sharemaestro market context Trend signal active 52 weeks +1.1% · Next-week setup positive 55.9% EHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Encompass Health (NYSE: EHC) director acquires 259 shares in awards

Encompass Health Corp director, Edward M. Christie III, acquired a total of 259 shares through various awards and deferrals on July 15 and 16, 2026. These transactions, which included restricted stock units from dividend payments and shares purchased via a deferred stock investment plan, …

EHC main company
Sharemaestro market context Trend signal active 52 weeks +1.1% · Next-week setup positive 55.9% EHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wellness Concepts in Grottoes acquired by Guardian Pharmacy Services

Guardian Pharmacy Services has acquired Wellness Concepts, a long-term care pharmacy based in Grottoes, Virginia. The acquisition means Wellness Concepts will retain its current leadership and staff, including President Brent Atwell, a second-generation pharmacist. This move strengthens Guardian Pharmacy Services' presence in Virginia and …

GRDN mentioned
Sharemaestro market context Trend signal active 52 weeks +49.0% GRDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LifeStance Sets Aug. 6 Call to Discuss Second-Quarter Results

LifeStance Health Group, Inc. (NASDAQ: LFST) will release its second-quarter 2026 earnings before market open on August 6, 2026. The company will host a live conference call at 8:30 a.m. Eastern Time on the same day to discuss the results, with dial-in and webcast …

LFST main company
Sharemaestro market context Trend signal active 52 weeks +123.8% LFST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Encompass Health (NYSE: EHC) awards 4 RSUs to non-employee director

Encompass Health (NYSE: EHC) awarded 4 Restricted Stock Units (RSUs) to non-employee director Cain A. Hayes on July 15, 2026. These RSUs were credited as dividend equivalents following a $0.19 per-share dividend when the stock closed at $109.88, increasing Hayes' total direct holdings to …

EHC main company
Sharemaestro market context Trend signal active 52 weeks +1.1% · Next-week setup positive 55.9% EHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

2 Reasons to Like ASTH and 1 to Stay Skeptical

Astrana Health (NASDAQ:ASTH), formerly Apollo Medical Holdings, has seen its stock price jump 79% in the last six months due to solid quarterly results. The company exhibits strong momentum with an annualized revenue growth of 38.3% and an impressive EPS growth of 13.2% over …

ASTH main company
Sharemaestro market context Trend signal active 52 weeks +33.0% ASTH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Universal Health Services Inc. Cl B stock underperforms Thursday when compared to competitors despite daily gains

Universal Health Services Inc. Cl B (UHS) stock advanced 3.73% on Thursday, closing at $153.54. Despite these daily gains, the stock underperformed compared to its competitors during an overall poor trading session for the market, with the S&P 500 Index and Dow Jones Industrial …

UHS main company
Sharemaestro market context Price below Trend Line 52 weeks -8.0% UHS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Truist Raises Price Target on Aveanna Healthcare Holdings to $11 From $9, Keeps Hold Rating

Truist has increased its price target for Aveanna Healthcare Holdings (AVAH) to $11, up from the previous $9. The firm has decided to maintain its Hold rating on the company's stock despite the price target adjustment. This indicates a revised valuation expectation while suggesting …

AVAH main company
Sharemaestro market context Trend signal active 52 weeks +64.9% AVAH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

HCA Healthcare (HCA) TD Cowen 46th Annual Health Care Conference Summary

HCA Healthcare presented at the TD Cowen 46th Annual Health Care Conference, outlining strategic initiatives to achieve $400 million in benefits by 2026 to offset ACA-related headwinds. They discussed financial modeling for potential ACA APTC expiration impacts and provided insights into operational trends, including …

HCA main company
Sharemaestro market context Price below Trend Line 52 weeks +0.6% · Next-week setup positive 55.4% HCA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MD5355101 Bond Risk Profile

The article provides a risk profile for the MD5355101 bond, issued by Pediatrix Medical Group, Inc. It highlights key metrics for credit risk assessment, including security level, inflation protection, and issuer rating. The profile aims to help investors evaluate the bond's reliability and make …

MD mentioned
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insider plans sale of 100 ENSG common shares in Form 144 filing (ENSG)

Mark Parkinson has filed a Form 144 notice to sell 100 common shares of ENSG stock through Fidelity Brokerage Services LLC, with a proposed sale date of July 16, 2026, for an aggregate value of $16,812. The shares vested as restricted stock on July …

ENSG main company
Sharemaestro market context Price below Trend Line 52 weeks +5.5% · Next-week setup positive 63.2% ENSG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 144 ENSIGN GROUP For: 16 July By Investing.com

This article announces the filing of Form 144 for ENSIGN GROUP (ENSG) on July 16, 2026, as reported by Investing.com. It is a brief administrative notice regarding market activity for the specified company. The content also briefly mentions other trending financial news and market …

ENSG main company
Sharemaestro market context Price below Trend Line 52 weeks +5.5% · Next-week setup positive 63.2% ENSG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PACS Group Inc stock hits all-time high at 45.89 USD

PACS Group Inc. stock has reached an all-time high of $45.89, representing a 270.43% increase over the past year. The company's market capitalization stands at $7.1 billion, with robust revenue growth of 22% and a perfect Piotroski Score of 9, indicating strong financial health. …

PACS main company
Sharemaestro market context Trend signal active 52 weeks +268.8% PACS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Medical Group (MD) Soars 7.3%: Is Further Upside Left in the Stock?

Pediatrix Medical Group (MD) shares rose 7.3% following an impressive volume and investor optimism regarding the company's Q2 2026 update. The company confirmed stable payor mix and reaffirmed its full-year 2026 Adjusted EBITDA outlook of $280-$300 million, with expected quarterly earnings of $0.57 per …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Analysts Offer Insights on Healthcare Companies: Pediatrix Medical Group (MD) and Travere Therapeutics (TVTX)

Healthcare sector analysts have provided insights on Pediatrix Medical Group (MD) and Travere Therapeutics (TVTX). Mizuho Securities maintained a Hold rating on Pediatrix Medical Group with a $27.00 price target, while Wedbush maintained a Buy rating on Travere Therapeutics with a $61.00 price target. …

MD main company
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Should COMP360’s Durable Phase 3 Results and FDA Momentum Require Action From COMPASS Pathways (CMPS) Investors?

COMPASS Pathways (CMPS) recently reported positive 26-week Phase 3 data for its COMP360 psilocybin candidate, showing rapid, durable symptom improvement for treatment-resistant depression with a well-tolerated safety profile. These results, coupled with an ongoing rolling New Drug Application and a more favorable FDA stance …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +191.8% CMPS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Precision Trading with Healthcare Services Group Inc. (HCSG) Risk Zones

This article analyzes Healthcare Services Group Inc. (HCSG) using AI models to suggest trading strategies. It identifies a near-term neutral sentiment with mid and long-term strength, highlighting specific entry, target, and stop-loss zones for long, breakout, and short positions. The analysis also provides multi-timeframe …

HCSG main company
Sharemaestro market context Trend signal active 52 weeks +36.9% HCSG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (HCA) and Syndax Pharmaceuticals (SNDX)

Analysts are presenting conflicting sentiments for HCA Healthcare (HCA) and Syndax Pharmaceuticals (SNDX). While Syndicate Pharmaceuticals received a Buy rating from Barclays with a $37.00 price target and a "Strong Buy" consensus, HCA Healthcare has seen its price target lowered by Jefferies and a …

HCA main company
Sharemaestro market context Price below Trend Line 52 weeks +0.6% · Next-week setup positive 55.4% HCA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pediatrix Medical Group Reiterates 2026 Adjusted EBITDA Outlook

Pediatrix Medical Group reaffirmed its 2026 adjusted EBITDA outlook, anticipating it to be between $400 million and $450 million. This reiteration provides financial guidance to investors regarding the company's future performance.

MD mentioned
Sharemaestro market context Trend signal active 52 weeks +56.4% MD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Chemed (NYSE:CHE) Reaches New 52-Week High - What's Next?

Chemed (NYSE:CHE) shares recently hit a new 52-week high of $497.25, closing at $492.96 with increased trading volume. Analyst sentiment is cautiously neutral with a consensus "Hold" rating and an average price target of $480.25, though Bank of America raised its target to $510. …

CHE main company
Sharemaestro market context Trend signal active 52 weeks +16.5% CHE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Guardian Pharmacy to report Q2 2026 results on August 6

Guardian Pharmacy Services will announce its second quarter 2026 financial results after market close on August 6, 2026, followed by a conference call at 4:30 p.m. Eastern Time. The company, which operates 61 licensed pharmacies serving approximately 207,000 residents, will host the call for …

GRDN main company
Sharemaestro market context Trend signal active 52 weeks +49.0% GRDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Discipline and Rules-Based Execution in CHE Response

This article provides an AI-generated analysis of Chemed Corp (NYSE: CHE), detailing key findings and institutional trading strategies. It highlights strong near and mid-term sentiment, potential for upside, and offers specific long, breakout, and risk-hedging strategies with entry points, targets, and stop losses. The …

CHE main company
Sharemaestro market context Trend signal active 52 weeks +16.5% CHE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context